Colorectal cancer clinical trials

Explore recruiting colorectal cancer clinical trials.

Recruiting colorectal cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Colorectal cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

RAXO trial - A population-based prospective study to evaluate clinical behaviour, resectability and survival in metastatic colorectal cancer patients in Finland

Finland

Therapeutic use (Phase IV) EU CTIS Study details

A phase II randomized clinical study of the combination of avelumab plus cetuximab as rechallenge strategy in pre-treated RAS/BRAF wild type metastatic colorectal cancer patients

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

– IKF/AIO-QUINTIS – A Randomized Phase II Trial Evaluating Fruquintinib in Combination with Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer without Active Liver Metastases

Germany, Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

Randomized Phase 2 Study of DKN-01 Plus FOLFIRI/FOLFOX and Bevacizumab Versus FOLFIRI/FOLFOX and Bevacizumab as Second-line Treatment of Advanced Colorectal Cancer (DeFianCe)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

OPTIMISE OPTIMIzation of treatment SElection and follow up in oligometastatic colorectal cancer – a ctDNA guided phase II randomized approach

Denmark, Norway, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized double-blind placebo-controlled study with ASA treatment in colorectal cancer patients with mutations in the PI3K signaling pathway

Finland, Sweden, Denmark, Norway

Therapeutic confirmatory (Phase III) EU CTIS Study details

Colorectal cancer trials by city

Colorectal cancer in Toronto Colorectal cancer in Vancouver Colorectal cancer in Montreal Colorectal cancer in Calgary Colorectal cancer in Edmonton Colorectal cancer in Ottawa Colorectal cancer in Winnipeg Colorectal cancer in Quebec City Colorectal cancer in Hamilton Colorectal cancer in Kitchener Colorectal cancer in London Colorectal cancer in Halifax Colorectal cancer in New York Colorectal cancer in Los Angeles Colorectal cancer in Chicago Colorectal cancer in Houston

Other conditions

Rosacea Alopecia areata Endometriosis Uterine fibroids Menopause Infertility Erectile dysfunction Enlarged prostate (BPH) Breast cancer Prostate cancer Lung cancer Non-small cell lung cancer Pancreatic cancer Ovarian cancer Melanoma Leukemia Lymphoma Multiple myeloma Bladder cancer Kidney cancer Liver cancer Glioblastoma Head and neck cancer Cervical cancer